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Abstract
Introduction: Membranous nephropathy (MN) in 
the context of rheumatoid arthritis (RA), is often an 
iatrogenic complication due to the nephrotoxic effects 
of antirheumatic drugs. Rare cases of non-iatrogenic 
association between these two diseases were reported in 
the literature. 
Case report: A 30-year-old female patient presented 
in September 2005 with nephrotic syndrome. Renal 
biopsy showed features consistent with MN. Search 
for etiology was negative, particularly lupus serology 
which remained negative throughout the course of her 
illness. Accordingly, she was diagnosed as a case of 
idiopathic MN. Initially, she was treated with angiotensin 
converting enzyme inhibitors and angiotensin receptor 
blockers which maintained her protein excretion below 
nephrotic range for two years. Her nephrotic syndrome 
then relapsed and was treated with steroids and 
chlorambucil, according to the Ponticelli protocol. A 
few months later, she presented with early morning joint 
stiffness, polyarthritis involving the small joints of the 
hands, and strongly positive rheumatoid factor, fulfilling 
the diagnostic criteria of rheumatoid arthritis (RA). Her 
serum creatinine remained normal and a second renal 
biopsy revealed the same features of MN. Her RA was 
treated with pulsed methylprednisolone followed by oral 
steroids and methotrexate resulting in remission of the 
joints disease and the nephrotic syndrome. Remission 
was maintained for the last two years up to the time of 
this report.
Conclusion: We hereby report a case of secondary 
membranous nephropathy that preceded the onset of 
rheumatoid arthritis by three years.
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Introduction
Membranous nephropathy (MN) is an important cause of 
adult nephrotic syndrome. It is characterized by fixation 
of immune deposits on the outer surface of the glomerular 
basement membrane followed by complement activation 
and damage to the basement membrane. The disease 
is commonly idiopathic, though secondary forms do 
exist [1]. Studies of MN in a murine model, Heymann’s 
nephritis, concluded that the subepithelial immune 
deposits characterizing the disease are formed in situ, as 
a result of excretion of a target antigen megalin, from 
the basal surface of podocytes. Megalin, together with 
circulating anti-megalin antibodies leads to immune 
complexe formation [2]. However, as megalin is not 
expressed in human podocytes, it was hypothesized that 
a similar process with an unknown antigen could be 
involved in human MN. Debiec et al [3] have confirmed 
the in situ formation of glomerular immune deposits 
in patients with MN. They described an allo-immune 
form of MN in newborns of mothers who are carriers 
of a deficit of a protein expressed on the podocytes, 
and to which they had been sensitized during previous 
pregnancies. Understanding the physiopathology of MN 
has improved lately by the discovery of a new target 
antigen that includes the M-Type Phospholipase A2 
Receptor (PLA2R), which seems to play a key role in the 
pathology of human MN [4].
On the other hand, rheumatoid arthritis (RA) is the most 
common chronic inflammatory rheumatic diseases. It 
had been reported to occur in about 0.5% of the total 
population, with women being affected four times more 
often than men. The disease commonly presents between 
35 to 55 years of age. It is characterized by chronic 
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inflammation of the synovial membranes of joints that 
gradually leads to the destruction of bone and cartilage 
and accordingly causes impairment of joints’ function. 
Rheumatoid arthritis is also a systemic disease with extra-
articular manifestations, particularly renal involvement. 
Affection of the kidneys often influences the prognosis 
of the disease [5]. 
MN in the context of RA is often an iatrogenic drug 
induced complication. It is mostly related to the use 
of gold, D-penicillamine and non-steroidal anti-
inflammatory drugs. Rare cases demonstrating a non-
iatrogenic association between these two pathologies has 
been reported in the literature. The existence of a causal 
link between the two entities is still in question. We report 
the clinical observation of a case of MN, considered 
idiopathic, that preceded the onset of RA by three years.
Case Report
A 30-year-old female patient, with no previous history of 
medical problems and no history of taking medications 
was initially hospitalized in our Nephrology Department 
in September 2005 for the management of newly 
diagnosed nephrotic syndrome. Investigations showed 
inactive urinary sediment and negative immunological 
analysis for antinuclear antibodies, anti-dsDNA 
antibodies, anti-SSa antibodies, anti-SSb antibodies, 
anti-Smith antibodies, anti-phospholipid antibodies and 
anti-neutophil cytoplasmic antibodies. Investigations 
also revealed normal C3 and C4 fractions of the serum 
complement, negative latex fixation test and Waaler 
Rose reaction, negative serological tests for bilharziasis, 
leishmaniasis, malaria, hydatidosis, hepatitis B and C 
viruses, negative Widal and Felix tests, normal chest 
X-ray and normal abdominal ultrasonography. Renal 
biopsy showed diffuse and moderate thickening of the 
glomerular basement membrane on light microscopy. 
Immunofluorescence study on a frozen fragment 
enclosing four glomeruli showed intense granular and 
diffuse staining with anti-IgG. Accordingly, the diagnosis 
of idiopathic MN was made. The patient was initially 
started on angiotensin converting enzyme inhibitors, 
angiotensin II receptor blockers and anti-platelets. 
Proteinuria diminished but was not eliminated, and was 
maintained in the sub-nephrotic range for two years. 
After that, a relapse of nephrotic syndrome occurred. The 
patient was switched to immunosuppressant therapy in 
the form of alternating corticosteroids and chlorambucil 
according to the Ponticelli protocol. Three months after 
initiation of immunosuppressant treatment, the patient 
presented with morning joint stiffness and polyarthritis, 
mostly involving the metacarpophalangeal (MCP) and the 
proximal interphalangeal (PIP) joints while sparing the 
distal interphalangeal joints (DIP). The knee joints were 
also affected. Further laboratory investigations showed 
an elevated erythrocyte sedimentation rate of 65 mm 
at one hour, and a C-reactive protein level of 12 mg/L. 
The Latex fixation test and the Waaler Rose reaction 
exceeded 256 UI/L. Serological screening for lupus was 
negative. Her complete blood count as well as C3 and 
C4 fragments of serum complement were normal. Her 
proteinuria remained within the nephrotic range and her 
renal function tests were normal. A second renal biopsy 
was taken; it showed the same previous renal histological 
lesions.  
These findings suggested the diagnosis of rheumatoid 
arthritis (RA) associated with idiopathic MN, given 
the presence of at least 4 diagnostic criteria according 
to the American College of Rheumatology (ACR), 
namely: morning joint stiffness lasting at least one hour, 
arthritis of at least 3 joint groups simultaneously, arthritis 
of at least one hand joint observed by a doctor and positive 
test for serum rheumatoid factor. At this early stage of 
the disease, imaging of the hands did not demonstrate 
significant erosive lesions. Furthermore, the diagnosis of 
RA was confirmed by the presence of strongly positive 
anti-cyclic citrullinated peptide antibodies (Anti-CCP) 
and anti-filaggrine antibodies by ELISA, with levels 
exceeding 340 UI/L and 10 UI/L, respectively. 
The patient was thus given pulsed methylprednisolone 
followed by oral prednisolone and Methotrexate. Two 
months after initiation of therapy, there was great 
improvement in the joint symptomatology and resolution 
of the nephrotic syndrome. Her protein excretion 
significantly dropped to a mean value of 0.5 ± 0.3 g/24h. 
Currently, two years after initiation of steroids and 
Methotrexate therapy, the patient remains in complete 
remission regarding her nephrotic syndrome as well as 
her joints’ disease.   
Discussion
The question raised by this clinical observation concerns 
the causal link between MN and RA in the absence of an 
iatrogenic cause. The diagnosis of early RA is usually 
difficult, being mostly based on clinical observations. 
In 70% of cases the suspicion of RA is raised by the 
presence of distal oligo-arthritis, and suggested by its 
localization at the MCP and PIP joints [5]; that was the 
case in our patient. In RA, the autoimmune hypothesis 
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was first raised upon identification of the first known 
auto-antibody, the rheumatoid factor, and in the absence 
of etiological factors such an infection preceding the 
disease. The presence of this auto-antibody and the 
specific consumption of the complement support the 
fact that RA is an immune complex-mediated disease 
appearing in predisposed individuals in response to a 
variety of inflammatory stimuli [6]. However, several 
questions remain unanswered, so far. It is not yet clear 
how an antibody directed against a ubiquitous antigen 
can lead to a pathology specific to joints. Also, the role 
of the rheumatoid factor, which differs from one disease 
to another, is not altogether understood. Furthermore, the 
mechanism for initiation of loss of self-tolerance remains 
unknown [6]. 
Renal abnormalities reported in patients with RA were 
mostly minimal change disease and MN. These were 
often related to the use of gold salts and D-penicillamine 
[7]. Outside the iatrogenic context, the most observed 
renal impairment in patients with RA is Type 1 
Membranoproliferative Glomerulonephritis (MPGN) 
with predominance of IgM and/or IgA immune deposits, 
together with C3 and C1q. IgG deposits were rarely seen 
in patients with MPGN due to RA. Other glomerular 
affections reported in patients with RA include focal 
necrotizing glomerulonephritis and mesangial or fibrillary 
glomerulonephritis [8-11].
Observing MN in a patient with RA and in the absence 
of prior use of any disease-modifying therapy remains 
exceptional in the literature. Kobayashi reported a case in 
which MN preceded the onset of RA by two years [12]. 
Honkanen also reported four cases with a similar scenario 
[13]. In our patient, MN preceded the onset of RA by three 
years. A causal relationship between these two pathologies 
remains questionable. In fact, the autoimmune nature of 
the two diseases raise the possibility of auto-antibodies 
with antigenic targets prevalent in both MN and RA, that 
can provide an explanation for the possible association 
between the two conditions. 
Conclusion
We report a female patient with secondary MN due to RA, 
with the renal involvement preceding joints involvement 
by more than three years.  It showed an abrupt response 
only to a disease modifying anti-rheumatic protocol. 
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